SCHEMBL4536069

SCHEMBL4536069

CC1CCN(C(=O)C2CCN(C(C(=O)NO)c3ccccc3)CC2)CC1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.56
TSHR P16473 3/20 0.52
USP2 O75604 1/20 0.47
CNR1 P21554 1/20 0.46
CNR2 P34972 1/20 0.46
KDM4E B2RXH2 3/20 0.46
ABCB1 P08183 1/20 0.45
ACHE P22303 1/20 0.44
HPGD P15428 1/20 0.43
CYP3A4 P08684 1/20 0.42
CYP2C19 P33261 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
RXRA P19793 1/20 0.41
RXRB P28702 1/20 0.41
RXRG P48443 1/20 0.41
POLB P06746 1/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4536524 0.88 TSHR (0.56) ALDH1A1TSHRCNR1CNR2HPGD
SCHEMBL27798401 0.86 ALDH1A1 (0.66) ALDH1A1TSHRCNR1CNR2KDM4E
SCHEMBL8120069 0.80 TSHR (0.49) ALDH1A1TSHRCYP3A4CYP2C19GAA
SCHEMBL8109453 0.76 TSHR (0.45) ALDH1A1TSHRCYP3A4CYP2C19GAA
SCHEMBL15081882 0.76 LMNA (0.65) ALDH1A1TSHRKDM4EACHECYP3A4
SCHEMBL2842489 0.76 TSHR (0.52) ALDH1A1TSHRCYP3A4CYP2C19GAA
Hydrochloric Acid SCHEMBL15063221 0.75 LMNA (0.68) ALDH1A1TSHRKDM4EACHECYP3A4
SCHEMBL2839009 0.74 SLC6A2 (0.54) TSHRPOLB
SCHEMBL2846505 0.73 GAA (0.68) ALDH1A1TSHRCYP3A4CYP2C19GAA
SCHEMBL2838023 0.73 HRH1 (0.51) ALDH1A1TSHRCYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096565-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2015-08-04 US disclosed
US-9096565-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2015-08-04 US disclosed
US-9096565-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2015-08-04 US disclosed
US-20090181943-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2009-07-16 US disclosed
US-20090181943-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2009-07-16 US disclosed
US-20090181943-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2009-07-16 US disclosed
WO-2008122115-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2008-10-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181943-A1 Inhibitors of Histone Deacetylase HDAC1, HDAC11, HDAC3 ALDH1A1 532/4885TSHR 3972/4885USP2 2231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.